2BB score and signals
Coherus Oncology, Inc.’s current 2BB score is 55 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 58 | Moderate |
| Momentum | 54 | Stable |
| Financial strength | 20 | Weak |
| Quality | 100 | Very Strong |
| Risk | 51 | Moderate |
Company facts
| CEO | Dennis Lanfear |
| Headquarters | Redwood City, California, United States |
| Founded | 2010 |
| Employees | 144 |
| 52-week range | $0.95 – $2.62 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-11-04 | — | -0.2239 | — | $16.33M |
| 2026-08-05 | — | -0.204 | — | $14.69M |
| 2026-05-11 | -0.25 | -0.2788 | $12.31M | $14.63M |
| 2026-03-09 | -0.34 | -0.3502 | $12.75M | $14.22M |
Related companies
2BBBullish & Bearish